|
Published by: Kalorama Information
Published: Aug. 1, 2007 - 200 Pages
Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
Market Potential
Epidemiology
Technology
Scope and Methodology
CHAPTER TWO: THE BASICS OF HEPATITIS, VIRUSES, ETIOLOGY
AND PATHOLOGY
Hepatitis A
- The Virus
- Etiology
- Pathology
Hepatitis B
- The Virus
- Etiology
Pathology
Hepatitis C
- The Virus
- Etiology
- Pathology
Hepatitis D
- The Virus
- Etiology
- Pathology
Hepatitis E
- The Virus
- Etiology
- Pathology
CHAPTER THREE: EPIDEMILOGY
Hepatitis A
- Geographic Patterns
- Age of Infection
- U.S. Hepatitis A Cases
Hepatitis B
- Geographic Patterns
- Risk to Children and Infants
- Vaccines
Hepatitis C
Hepatitis D
Hepatitis E
CHAPTER FOUR: HEPATITIS DIAGNOSIS, PROPHYLAXIS AND
THERAPEUTICS
Hepatitis A
- Diagnosis
- Prophylaxis
- Therapeutics
Hepatitis B
- Diagnosis
- Prophylaxis
- Therapy
Hepatitis C
- Diagnosis
- Prophylaxis
- Therapy
Hepatitis D
- Diagnosis
- Prophylaxis
- Therapy
Hepatitis E
- Diagnosis
- Prophylaxis
- Therapy
CHAPTER FIVE: STRATEGIC ASSESSMENT AND MARKET
ANALYSIS
Hepatitis Policy
Comprehensive Prevention Strategy
Hepatitis C Prevention
Market Potential
Theoretical Market Assessment
Diagnostics and Screening Markets
Therapeutics: Vaccines and Antivirals
Pricing Considerations
Realistic Market Assessment
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006
Figure 1-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products
and Therapeutics Market Potential: 2006
Table 1-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006 (Millions)
Figure 1-2: Theoretical Distribution of Global Hepatitis (All Types) Testing Products (Screening and Diagnosis) Market Potential: 2006
Table 1-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006
Figure 1-3: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic
Products Market Potential: 2006
Table 1-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006 (Millions)
Figure 1-4 The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Testing Products and Therapeutics Market Potential: 2006
Table 1-5 A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products: 2006 (Millions)
Figure 1-5: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Testing Products Market Potential: 2006
Table 1-6 A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006
Figure 1-6 The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential: 2006
Table 1-7: Global Prevalence of Hepatitis (All Types): 2006 (Millions)
Figure 1-7: The Distribution of Global Hepatitis (All Types) Prevalence: 2006
CHAPTER TWO: THE BASICS OF HEPATITIS, VIRUSES, ETIOLOGY AND PATHOLOGY
Table 2-1 The Hepatitis Viruses
CHAPTER THREE: EPIDEMILOGY
Table 3-1 Worldwide Endemicity of HAV Infection
Table 3-2: Prevalence of Hepatitis B in Various regions of the World
Table 3-3: Hepatitis C Estimated Prevalence and Number Infected by
WHO Region: 2000
Table 3-2: Prevalence of Hepatitis B in Various regions of the World
CHAPTER FOUR: HEPATITIS DIAGNOSIS, PROPHYLAXIS AND
THERAPEUTICS
Table 4-1: HBV Serological Markers in Hepatitis Patients
Table 4-2: Commercially Available HBV (Antigen and Antibody) Assays
Table 4-3: Significance of Serological Marker Tests for HBV (HBsAg, antiHBs,
anti HBc and Interpretation)
Table 4-4: Serological Test Findings at Different Stages of HBV Infection and
in Convalescence
Table 4-5: Key Hepatitis B Vaccines* Available Internationally (Producer, Vaccine,
Country, Type)
Table 4-6: General Description of Useful Assay Technologies in the Diagnosis of
Hepatitis C
Table 4-7 Commercially Available HCV (Antigen and Antibody) Assays
CHAPTER FIVE: STRATEGIC ASSESSMENT AND MARKET ANALYSIS
Table 5-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types)
Testing Products and Therapeutics: 2006
Figure 5-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products
and Therapeutics Market Potential: 2006
Table 5-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006
Figure 5-2: Theoretical Distribution of the Total Global Hepatitis (All Types) Testing
Products Market Potential: 2006
Figure 5-3: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Screening: 2006
Figure 5-4: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Diagnosis: 2006
Table 5-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006
Figure 5-5: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic Products Market Potential: 2006
Figure 5-6: Theoretical Distribution of Global Hepatitis (All Types) Vaccine Market
Potential: 2006
Figure 5-7: Theoretical Distribution of Global Hepatitis (All Types) Antiviral Drug Market Potential: 2006
Table 5-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006 (in millions)
Figure 5-8: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Testing Products and Therapeutics Market Potential: 2006
Table 5-5: A Realistic Estimation Global Market Potentials for Hepatitis (All Types)
Testing Products: 2006
Figure 5-9: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Market Potential for Testing Products: 2006
Figure 5-10: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Market Potential for Testing Products in Screening: 2006
Figure 5-11: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Market Potential for Testing Products in Diagnosis: 2006
Table 5-6: A Realistic Estimation Global Market Potentials for Hepatitis
(All Types) Therapeutics: 2006
Figure 5-12: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Therapeutics Market Potential: 2006
Figure 5-13: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Therapeutics Market Potential --- Vaccines: 2006
Figure 5-14: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential --- Antiviral Drugs: 2006
Table 5-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006
Figure 5-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products
and Therapeutics Market Potential: 2006
Table 5-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006
Figure 5-2: Theoretical Distribution of the Total Global Hepatitis (All Types) Testing
Products Market Potential: 2006
Figure 5-3: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Screening: 2006
Figure 5-4: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Diagnosis: 2006
Table 5-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types)
Therapeutics: 2006
Figure 5-5: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic Products Market Potential: 2006
Figure 5-6: Theoretical Distribution of Global Hepatitis (All Types) Vaccine Market Potential: 2006
Figure 5-7 Theoretical Distribution of Global Hepatitis (All Types) Antiviral Drug Market Potential: 2006
Table 5-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types)
Testing Products and Therapeutics: 2006
Figure 5-8: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Testing Products and Therapeutics Market Potential: 2006
Table 5-5: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products: 2006
Figure 5-9: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Market Potential for Testing Products: 2006
Figure 5-10: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Market Potential for Testing Products in Screening: 2006
Figure 5-11: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Market Potential for Testing Products in Diagnosis: 2006
Table 5-6: A Realistic Estimation Global Market Potentials for Hepatitis (All Types)
Therapeutics: 2006
Figure 5-12: The Distribution of Realistic Estimates of Global Hepatitis (All Types)
Therapeutics Market Potential: 2006
Figure 5-13: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential --- Vaccines: 2006
Figure 5-14: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential --- Antiviral Drugs: 2006
AbstractThe unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles.
In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. advises companies to think on a global basis. In this study, Global Hepatitis Strategies Krul examines the potential market, epidemiology (hepatitis patient trends) and technology to provide a clear understanding of the opportunities and challenges awaiting companies competing in this market.
As part of the market analysis this report includes - Extensive Statistics of Incidence and Prevalence of Hepatitis Across the 6 Major WHO Regions (Americas, Europe, Africa, Western Pacific, Southeast Asia, Eastern Mediterranean)
- Etiology, Prophylaxis, and Therapy for Hepatitis A, B, C, D and E.
- Theoretical Revenues for Diagnosis, Screening and Therapeutics representing the potential marketplace if all screening options are pursued.
- Realistic Market Revenues representing the likely marketplace.
- Global Distribution of Therapeutics and Diagnostics Revenues across Major 6 WHO regions
- Over 40 Figures and Tables making information accessible.
Product managers, Marketing executives at pharmaceutical and diagnostic companies; as well as investment professionals are among those who will find this survey a critical resource.
Get Full Details About This Report >>
|
